好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2025 Annual Meeting | C87 - Epilepsy Therapy Update

Monday 04/07/25
07:00 AM - 09:00 AM PDT Add To Calendar
San Diego Convention Center | 31AB
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Anteneh M. Feyissa, MD, MSc, FAAN
Epilepsy/Clinical Neurophysiology (EEG)
Participants should become familiar with all currently approved antiseizure medications in the US and how to tailor each drug by etiology of epilepsy; be aware of all surgical modalities, including minimally invasive therapies; and become familiar with neuromodulatory devices for the treatment of epilepsy, including responsive neurostimulation and deep brain stimulation.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement
Intermediate
Fellow, Resident, General Neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student
Didactic

Program Materials Program Evaluations

Event Timeline
07:00 AM - 07:03 AM PDT Introduction Introduction
Anteneh M. Feyissa, MD, MSc, FAAN
07:03 AM - 07:38 AM PDT Speaker Update in Antiseizure Medication: Focus on Acute Symptomatic Seizures and Seizure Emergencies
Brin Freund, MD
07:38 AM - 08:13 AM PDT Speaker What is New in Neuromodulation Therapy for Epilepsy
David E. Burdette, MD
08:13 AM - 08:50 AM PDT Speaker Advances in Epilepsy Surgery
Adriana C. Bermeo Ovalle, MD, FAAN
08:50 AM - 09:00 AM PDT Speaker Questions and Discussions
Brin Freund, MD, David E. Burdette, MD, Anteneh M. Feyissa, MD, MSc, FAAN, Adriana C. Bermeo Ovalle, MD, FAAN
Faculty Disclosures
Anteneh M. Feyissa, MD, MSc, FAAN Dr. Feyissa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis.
Brin Freund, MD Dr. Freund has received research support from Mayo Clinic.
David E. Burdette, MD Dr. Burdette has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Burdette has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Catalyst. Dr. Burdette has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. Dr. Burdette has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life pharmaceuticals. Dr. Burdette has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for NeuroPace. Dr. Burdette has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Burdette has received research support from Longboard. The institution of Dr. Burdette has received research support from NeuroPace.
Adriana C. Bermeo Ovalle, MD, FAAN An immediate family member of Dr. Bermeo Ovalle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bioserenity. An immediate family member of Dr. Bermeo Ovalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. An immediate family member of Dr. Bermeo Ovalle has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurelis Inc.. An immediate family member of Dr. Bermeo Ovalle has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK Life Science. An immediate family member of Dr. Bermeo Ovalle has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal on Clinical Neuropysiology. An immediate family member of Dr. Bermeo Ovalle has received publishing royalties from a publication relating to health care.